Assignee
CELGENE QUANTICEL RES INC
US·95 granted patents·13 pending applications·148 citations·filing 2013–2024
Top patents by PatentIndex Score
108 records- 0196US11084793B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2020·Granted Aug 10, 2021·3 cites·24 claims
- 0295US10941160B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Mar 9, 2021·3 cites·25 claims
- 0395US10023592B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jul 17, 2018·11 cites·27 claims
- 0494US11535616B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 27, 2022·2 cites·13 claims
- 0593US10316016B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Jun 11, 2019·4 cites·8 claims
- 0693US10112940B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 30, 2018·4 cites·6 claims
- 0793US9598372B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2015·Granted Mar 21, 2017·10 cites·31 claims
- 0893US9586902B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Mar 7, 2017·5 cites·30 claims
- 0992US11464771B2Bromodomain and extra-terminal protein inhibitor combination therapyCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 11, 2022·2 cites·15 claims
- 1092US10815234B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 27, 2020·2 cites·9 claims
- 1192US10208039B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 19, 2019·4 cites·8 claims
- 1292US10202381B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 12, 2019·4 cites·24 claims
- 1392US10047069B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 14, 2018·4 cites·3 claims
- 1492US9815828B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Nov 14, 2017·4 cites·36 claims
- 1591US10059687B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Aug 28, 2018·4 cites·17 claims
- 1691US10030017B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Jul 24, 2018·4 cites·4 claims
- 1791US9771329B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Sep 26, 2017·6 cites·19 claims
- 1890US10703739B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2019·Granted Jul 7, 2020·2 cites·11 claims
- 1990US10654810B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·2 cites·19 claims
- 2090US10023543B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Jul 17, 2018·4 cites·2 claims
- 2190US2025066355A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2024·Application pending·0 cites
- 2289US11020380B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jun 1, 2021·2 cites·27 claims
- 2389US10611763B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 7, 2020·2 cites·7 claims
- 2489US10166227B2Bromodomain and extra-terminal protein inhibitor combination therapyCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 1, 2019·6 cites·11 claims
- 2589US9776974B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Oct 3, 2017·4 cites·19 claims
- 2688US11890275B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2021·Granted Feb 6, 2024·1 cites·44 claims
- 2788US11214542B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Jan 4, 2022·1 cites·17 claims
- 2888US9828358B2Compositions comprising an inhibitor of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2016·Granted Nov 28, 2017·5 cites·20 claims
- 2988US2024182490A1Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2023·Application pending·0 cites
- 3087US2023286917A1Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2023·Application pending·0 cites
- 3186US10807956B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Oct 20, 2020·1 cites·18 claims
- 3286US10207999B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2017·Granted Feb 19, 2019·2 cites·2 claims
- 3385US12172998B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2022·Granted Dec 24, 2024·0 cites·13 claims
- 3485US10870634B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted Dec 22, 2020·1 cites·11 claims
- 3585US10807982B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2019·Granted Oct 20, 2020·2 cites·14 claims
- 3685US10617680B2Therapeutic compoundsCELGENE QUANTICEL RES INC·Filed 2018·Granted Apr 14, 2020·3 cites·48 claims
- 3785US10543213B2Treatment of relapsed and/or refractory solid tumors and non-hodgkin's lymphomasCELGENE QUANTICEL RES INC·Filed 2019·Granted Jan 28, 2020·1 cites·5 claims
- 3885US9908885B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2016·Granted Mar 6, 2018·4 cites·24 claims
- 3985US9873697B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 23, 2018·3 cites·20 claims
- 4085US9725441B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Aug 8, 2017·2 cites·20 claims
- 4184US11001568B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2020·Granted May 11, 2021·1 cites·14 claims
- 4284US10562915B2Bromodomain inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Feb 18, 2020·2 cites·12 claims
- 4383US10654830B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted May 19, 2020·1 cites·5 claims
- 4483US10597365B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Mar 24, 2020·1 cites·14 claims
- 4583US10106534B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2018·Granted Oct 23, 2018·1 cites·25 claims
- 4683US9994561B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jun 12, 2018·1 cites·35 claims
- 4783US9822119B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2015·Granted Nov 21, 2017·3 cites·20 claims
- 4882US10385051B2Inhibitors of lysine specific demethylase-1CELGENE QUANTICEL RES INC·Filed 2018·Granted Aug 20, 2019·2 cites·45 claims
- 4982US10179769B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Jan 15, 2019·1 cites·14 claims
- 5082US9828343B2Histone demethylase inhibitorsCELGENE QUANTICEL RES INC·Filed 2017·Granted Nov 28, 2017·1 cites·12 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when CELGENE QUANTICEL RES INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →